Add this result to my export selection Revised SPC: Cimzia (certolizumab pegol) – all presentations Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 30 October 2020 Kaposi’s sarcoma has been added as an adverse event (frequency unknown). Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Ovestin (estriol) cream Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 24 November 2020 SPC now states that epidemiological evidence from a large meta-analysis suggests no increased risk of breast cancer in women with no history of breast cancer taking low dose vaginal oestrogens, but... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Humira (adalimumab) – all presentations Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 06 December 2020 SPC has been updated with license extension for treatment of ulcerative colitis in patients from 6 years of age who have had an inadequate response to corticosteroids and/or 6-mercaptopurine or... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Praluent (alirocumab) 75 and 150 mg solution for injection in pre-filled pen Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 December 2020 SPC updated to advise that experience of alirocumab in paediatric patients is limited to 18 patients aged 8 to 17 years with homozygous familial hypercholesterolaemia. No new safety finding was... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Kanuma (sebelipase alfa) 2mg/ml concentrate solution Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 December 2020 SPC has been revised with further dosing information and safety data based on 125 patients exposed to sebelipase alfa at doses ranging from 0.35 mg/kg once every other week to 7.5 mg/kg once weekly... Read Summary SPS comment Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Lyrica (pregabalin) - all products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 December 2020 SPC updated to warn of reports of severe respiratory depression in relation to pregabalin use; dose adjustments may be necessary in at risk patients (e.g. compromised respiratory function, ... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Tasigna (nilotinib) Hard Capsules- all strengths Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 December 2020 SPC has been updated with warning about the combination of nilotinib with those statins that are mainly eliminated by CYP3A4, may increase the potential for statin-induced myopathy, including... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Recarbrio (imipenem / cilastatin / relebactam) powder for solution for infusion Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 27 November 2020 SPC now includes details for the licence extension for use in adults with hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP), and treatment of bacteraemia that occurs... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Xagrid (anagrelide) 0.5mg hard capsule Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 27 November 2020 SPC notes that CYP1A2 inducers (such as omeprazole) could decrease the exposure of anagrelide, therefore, clinical and biological monitoring is recommended in patients taking concomitant CYP1A2... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Feldene (piroxicam) products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 26 November 2020 SPC now warns that Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS syndrome) have been reported very rarely in association with the use of NSAIDs. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)